In Vitro Diagnostic (IVD) Labware Global Market Report 2026

The in vitro diagnostic (IVD) labware market size has grown strongly in recent years. It will grow from $4.2 billion in 2025 to $4.51 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increasing prevalence of infectious diseases, expansion of clinical laboratory networks, growth in hospital diagnostic services, rising demand for routine blood and urine testing, adoption of standardized laboratory protocols.

The in vitro diagnostic (IVD) labware market size is expected to see strong growth in the next few years. It will grow to $6.06 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to growing investment in molecular and genetic testing, increasing automation in diagnostic laboratories, rising demand for point of care testing support, expansion of healthcare infrastructure in emerging markets, increasing focus on sustainable laboratory consumables. Major trends in the forecast period include increasing adoption of single-use disposable labware, rising demand for high-precision sample handling tools, growing integration of automation-compatible labware, expansion of molecular diagnostics testing volumes, rising focus on contamination control and biosafety standards.

The rising incidence of infectious diseases is expected to drive the growth of the in vitro diagnostics (IVD) labware market in the coming years. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, which can spread from person to person or through environmental exposure. The incidence of infectious diseases is increasing due to growing urbanization and population density, which foster closer human contact and accelerate pathogen transmission. In vitro diagnostics (IVD) labware facilitates the detection, monitoring, and management of infectious diseases by enabling accurate and timely testing of blood, tissue, and other biological samples, helping healthcare professionals identify pathogens, track outbreaks, and implement appropriate treatment and prevention measures. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, reflecting an increase of 1,295 cases. Therefore, the rising incidence of infectious diseases is driving the growth of the in vitro diagnostics (IVD) labware market.

Leading companies operating in the in vitro diagnostics (IVD) labware market are focusing on developing innovative products such as IVD-compliant refrigerated centrifuges to enhance diagnostic accuracy and ensure regulatory compliance. IVD-compliant refrigerated centrifuges are specialized laboratory devices that separate biological samples under strict regulatory standards while maintaining precise temperature control, helping ensure accurate test results, reproducibility, and safe handling of clinical specimens. For example, in December 2025, OHAUS Corporation, a US-based laboratory equipment manufacturing company, launched the frontier multi-pro, multi, and micro IVD series compliant centrifuges, a cutting-edge line of IVD-compliant refrigerated centrifuges designed to meet the rigorous demands of clinical diagnostics. These compliant centrifuges feature natural R290 refrigerant, which has a warming potential of only 3, over 700 times lower than conventional synthetic coolants, while maintaining precise temperature control for sensitive biological samples. The frontier IVD Series offers versatile applications across hospitals, diagnostic centers, and research laboratories, ensuring high reproducibility, safety, and efficiency in in vitro testing.

In March 2023, Werfen S.A., a Spain-based healthcare technology company, acquired Immucor Inc. for $2 billion. With this acquisition, Werfen S.A. aimed to broaden its portfolio of specialized diagnostics solutions for hospitals and clinical laboratories, strengthening its leadership in the Transfusion and Transplant markets. Immucor Inc. is a US-based healthcare technology company focusing on in vitro diagnostics products that ensure patient-donor compatibility in transfusion and transplant settings.

Major companies operating in the in vitro diagnostics (IVD) labware market are market are Thermo Fisher Scientific Inc., Abbott Laboratories, Corning Incorporated, Avantor Inc., bioMérieux SA, Sartorius AG, Sysmex Corporation, Greiner AG, QIAGEN N.V., Eppendorf SE, Sarstedt AG & Co. KG, Azenta Inc., Biolyst Scientific Inc., Zhejiang Bioland Biotechnology Co. Ltd., WuXi NEST Biotechnology Co. Ltd., Tarsons Products Limited, Abdos Group, Heathrow Scientific LLC, Labcon North America Inc., Kangjian Medical Apparatus Co. Ltd., Accumax Lab Devices Pvt. Ltd.

North America was the largest region in the in vitro diagnostics (IVD) labware market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostics (IVD) labware market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the in vitro diagnostics (IVD) labware market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in vitro diagnostics (IVD) labware market consists of sales of sample collection tubes, vacutainer tubes, micro centrifuge tubes, petri dishes, culture plates, assay plates, pipette tips, and reagent reservoirs. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In vitro diagnostics (IVD) labware refers to specialized instruments and equipment used to conduct diagnostic testing on samples outside a living organism. These tools are designed to handle, process, and analyze biological materials, including blood, urine, or tissue, to detect diseases, conditions, or infections. They ensure testing accuracy, reliability, and safety by supporting precise measurement, containment, and manipulation of samples.

The primary product types of in vitro diagnostics (IVD) labware include plastic labware, glass labware, and other variants. Plastic labware consists of durable or disposable laboratory tools designed to handle biological samples safely and efficiently, available as single-use or reusable. Applications include clinical chemistry, immunoassays, molecular diagnostics, hematology, microbiology, and others, serving clinical laboratories, hospitals, academic institutes, and other end-users.

Tariffs on imported plastic resins, specialty glass, and laboratory manufacturing equipment are impacting the in vitro diagnostics labware market by increasing production and procurement costs, particularly affecting single-use plastic labware and precision glassware segments. Regions such as North America and Europe that rely on global raw material supply chains are most affected, along with emerging markets dependent on imported consumables. Higher costs may pressure hospital and clinical laboratory budgets. However, tariffs are also encouraging domestic manufacturing of diagnostic consumables, promoting local supply chain resilience, and stimulating innovation in cost-effective and sustainable labware production.

The in vitro diagnostics (IVD) labware market research report is one of a series of new reports that provides in vitro diagnostics (IVD) labware market statistics, including in vitro diagnostics (IVD) labware industry global market size, regional shares, competitors with a in vitro diagnostics (IVD) labware market share, detailed in vitro diagnostics (IVD) labware market segments, market trends and opportunities, and any further data you may need to thrive in the in vitro diagnostics (IVD) labware industry. This in vitro diagnostics (IVD) labware market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.